RM
+
Illustration showing repaglinide (yellow white blue and red spheres centre-left and centre-right) binding to an ATP-dependent potassium channel (mu
RM
+
Illustration showing repaglinide (yellow red and white spheres centre-left and centre-right) binding to an ATP-dependent potassium channel (multicol
RM
+
Illustration showing repaglinide (yellow white blue and red spheres centre-left and centre-right) binding to an ATP-dependent potassium channel (mu
RM
+
Illustration showing repaglinide (yellow white blue and red spheres within pink structures) binding to ATP-dependent potassium channel (multicoloure
RM
+
Illustration showing repaglinide (white blue and red spheres within helices) binding to an ATP-dependent potassium channel (multicoloured helices) on
RM
+
Illustration showing the molecular structure of repaglinide a drug used to treat type 2 diabetes It belongs to a class of drug known as meglitinides
RM
+
Illustration showing the molecular structure of repaglinide a drug used to treat type 2 diabetes It belongs to a class of drug known as meglitinides
RM
+
Illustration showing the molecular structure of repaglinide a drug used to treat type 2 diabetes It belongs to a class of drug known as meglitinides
RM
+
Illustration showing the molecular structure of repaglinide a drug used to treat type 2 diabetes It belongs to a class of drug known as meglitinides
9
0
https://www.afloimages.com/search/enyglid.html